Results 41 to 50 of about 836,621 (308)

The 18S ribosomal RNA m6A methyltransferase Mettl5 is required for normal walking behavior in Drosophila

open access: yes, 2020
RNA modifications have recently emerged as an important layer of gene regulation. N6-methyladenosine (m6A) is the most prominent modification on eukaryotic messenger RNA and has also been found on noncoding RNA, including ribosomal and small nuclear RNA.
Jessica Leismann   +39 more
core   +1 more source

The m6A‑methylase complex and mRNA export [PDF]

open access: yes, 2019
During synthesis, mRNA undergoes a number of modifications such as capping, splicing and polyadenylation. These processes are coupled with the orderly deposition of the TREX complex on the mRNA and subsequent recruitment of the NXF1-P15 heterodimer which
Wilson, S.A., Lesbirel, S.
core   +1 more source

The Tudor SND1 protein is an m6A RNA reader essential for replication of Kaposi’s sarcoma-associated herpesvirus [PDF]

open access: yes, 2019
N6-methyladenosine (m6A) is the most abundant internal RNA modification of cellular mRNAs. m6A is recognised by YTH domain-containing proteins, which selectively bind to m6A-decorated RNAs regulating their turnover and translation.
Wilson, S.A.   +23 more
core   +1 more source

The current landscape of m6A modification in urological cancers

open access: yesPeerJ, 2023
N6-methyladenosine (m6A) methylation is a dynamic and reversible procession of epigenetic modifications. It is increasingly recognized that m6A modification has been involved in the tumorigenesis, development, and progression of urological tumors. Emerging research explored the role of m6A modification in urological cancer.
Zeng, Yaohui   +3 more
openaire   +3 more sources

The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis

open access: yesFrontiers in Genetics, 2021
The N6-methyladenosine (m6A) modification is the most abundant epitranscriptomic modification in eukaryotic messenger RNA (mRNA). The m6A modification process is jointly regulated by various enzymes and proteins, such as methyltransferases, demethylases ...
Jie Fu   +8 more
doaj   +1 more source

Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases

open access: yesCell & Bioscience, 2021
Autophagy is a conserved degradation process crucial to maintaining the primary function of cellular and organismal metabolism. Impaired autophagy could develop numerous diseases, including cancer, cardiomyopathy, neurodegenerative disorders, and aging ...
Xuechai Chen   +6 more
doaj   +1 more source

Structural Insights into N6-methyladenosine (m6A) Modification in the Transcriptome

open access: yesGenomics, Proteomics & Bioinformatics, 2018
More than 100 types of chemical modifications in RNA have been well documented. Recently, several modifications, such as N6-methyladenosine (m6A), have been detected in mRNA, opening the window into the realm of epitranscriptomics.
Jinbo Huang, Ping Yin
doaj   +1 more source

Identification of New m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Landscape that Predict Clinical Outcomes for Papillary Renal Cell Carcinoma Patients

open access: yesFrontiers in Cell and Developmental Biology, 2022
N6-methyladenosine (m6A) is the product of the most prevalent mRNA modification in eukaryotic cells. Accumulating evidence shows that tumor microenvironment (TME) plays a pivotal role in tumor development. However, the underlying relationship between m6A
Bin Zheng   +16 more
doaj   +1 more source

The m6A-methylase complex recruits TREX and regulates mRNA export [PDF]

open access: yes, 2018
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic mRNA. This modification has previously been shown to alter the export kinetics for mRNAs though the molecular details surrounding this phenomenon remain poorly understood ...
Wilson, S.A.   +6 more
core   +1 more source

m6A modification: recent advances, anticancer targeted drug discovery and beyond

open access: yesMolecular Cancer, 2022
Abnormal N6-methyladenosine (m6A) modification is closely associated with the occurrence, development, progression and prognosis of cancer, and aberrant m6A regulators have been identified as novel anticancer drug targets.
Li-Juan Deng   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy